| Item Type | Name |
|
Concept
|
Hepatitis B e Antigens
|
|
Concept
|
Hepatitis, Alcoholic
|
|
Concept
|
Hepatitis B
|
|
Concept
|
Hepatitis C
|
|
Concept
|
Hepatitis
|
|
Concept
|
Hepatitis B Surface Antigens
|
|
Concept
|
Hepatitis, Viral, Human
|
|
Concept
|
Hepatitis B, Chronic
|
|
Concept
|
Hepatitis E
|
|
Concept
|
Hepatitis E virus
|
|
Concept
|
Hepatitis C, Chronic
|
|
Concept
|
Hepatitis, Autoimmune
|
|
Concept
|
Hepatitis B virus
|
|
Concept
|
Hepatitis C Antibodies
|
|
Academic Article
|
Prevalence of TT virus infection in blood donors with elevated ALT in the absence of known hepatitis markers.
|
|
Academic Article
|
Recurrent autoimmune hepatitis after orthotopic liver transplantation.
|
|
Academic Article
|
Apolipoprotein synthesis in nonalcoholic steatohepatitis.
|
|
Academic Article
|
Differential allograft gene expression in acute cellular rejection and recurrence of hepatitis C after liver transplantation.
|
|
Academic Article
|
A clinician's guide to drug-drug interactions with direct-acting antiviral agents for the treatment of hepatitis C viral infection.
|
|
Academic Article
|
Hepatitis G virus infection in patients transplanted for cryptogenic cirrhosis: red flag or red herring?
|
|
Academic Article
|
Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantation.
|
|
Academic Article
|
Broadly neutralizing antibodies abrogate established hepatitis C virus infection.
|
|
Academic Article
|
Lack of health insurance limits the benefits of hepatitis C virus screening: insights from the National Health and Nutrition Examination Hepatitis C follow-up study.
|
|
Academic Article
|
Natural history and management of hepatitis C infection after liver transplantation.
|
|
Academic Article
|
A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C.
|
|
Academic Article
|
Recipient IL28B polymorphism is an important independent predictor of posttransplant diabetes mellitus in liver transplant patients with chronic hepatitis C.
|
|
Academic Article
|
Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation.
|
|
Academic Article
|
Interleukin-28B and fibrosing cholestatic hepatitis in posttransplant hepatitis C: a case-control study and literature review.
|
|
Academic Article
|
Response to Fibrosis progression in patients treated for hepatitis C recurrence.
|
|
Academic Article
|
Recurrent and new hepatitis C virus infection after liver transplantation.
|
|
Academic Article
|
A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation.
|
|
Academic Article
|
Pre-emptive treatment of recurrent hepatitis C infection.
|
|
Academic Article
|
Clinical significance of TT virus infection in patients with chronic hepatitis C.
|
|
Academic Article
|
Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C.
|
|
Academic Article
|
Early detection of hepatitis C allograft reinfection after orthotopic liver transplantation: a molecular and histologic study.
|
|
Academic Article
|
Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation.
|
|
Academic Article
|
Mycophenolate and hepatitis C: salve on a wound or gasoline on a fire?
|
|
Academic Article
|
Hepatitis C infection in liver transplantation.
|
|
Academic Article
|
Retransplantation for HCV--the view through a broken crystal ball.
|
|
Academic Article
|
Predictors of patient and graft survival following liver transplantation for hepatitis C.
|
|
Academic Article
|
Comparative allograft histology after liver transplantation for cryptogenic cirrhosis, alcohol, hepatitis C, and cholestatic liver diseases.
|
|
Academic Article
|
The pathogenesis of hepatitis C virus is influenced by cytomegalovirus.
|
|
Academic Article
|
The impact of advancing donor age on histologic recurrence of hepatitis C infection: the perils of ignored maternal advice.
|
|
Academic Article
|
Characterization of hepatitis B virus surface antigen and polymerase mutations in liver transplant recipients pre- and post-transplant.
|
|
Academic Article
|
Management of recurrence of hepatitis C infection following liver transplantation.
|
|
Academic Article
|
Origin of adenocarcinoma in a transplanted liver determined by microsatellite analysis.
|
|
Academic Article
|
Natural history of hepatitis C and outcomes following liver transplantation.
|
|
Academic Article
|
Long-term results and modeling to predict outcomes in recipients with HCV infection: results of the NIDDK liver transplantation database.
|
|
Academic Article
|
Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis.
|
|
Academic Article
|
A practical guide to the management of HCV infection following liver transplantation.
|
|
Academic Article
|
Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
|
|
Academic Article
|
Patient and graft survival following liver transplantation for hepatitis C: much ado about something.
|
|
Academic Article
|
Liver biopsy, viral kinetics, and the impact of viremia on severity of hepatitis C virus recurrence.
|
|
Academic Article
|
Monoclonal antibody HCV-AbXTL68 in patients undergoing liver transplantation for HCV: results of a phase 2 randomized study.
|
|
Academic Article
|
Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study.
|
|
Academic Article
|
Recurrence of hepatitis C infection: Where are we now?
|
|
Academic Article
|
Branched-chain amino acid enriched supplements as therapy for liver disease.
|
|
Academic Article
|
Perioperative viral kinetics: new insights or the Emperor's new clothes?
|
|
Academic Article
|
Approach to recurrent hepatitis C following liver transplantation.
|
|
Academic Article
|
Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection.
|
|
Academic Article
|
Impact of depressive symptoms and their treatment on completing antiviral treatment in patients with chronic hepatitis C.
|
|
Academic Article
|
Introduction to the genetics and biology of interleukin-28B.
|
|
Academic Article
|
Impact of sirolimus and tacrolimus on mortality and graft loss in liver transplant recipients with or without hepatitis C virus: an analysis of the Scientific Registry of Transplant Recipients Database.
|
|
Academic Article
|
Nutritional status of patients with alcoholic cirrhosis undergoing liver transplantation: time trends and impact on survival.
|
|
Academic Article
|
Impact of obesity on treatment of chronic hepatitis C.
|
|
Academic Article
|
Insulin resistance, serum adipokines and risk of fibrosis progression in patients transplanted for hepatitis C.
|
|
Academic Article
|
The clinical significance of simultaneous infection with hepatitis G virus in patients with chronic hepatitis C.
|
|
Academic Article
|
Genotype 1b and severity of posttransplant recurrence of hepatitis C infection- unconvictable felon or wrongly accused?
|
|
Academic Article
|
Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin: lessons on tolerability and efficacy.
|
|
Academic Article
|
Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.
|
|
Academic Article
|
Impact of fibrosis progression on clinical outcome in patients treated for post-transplant hepatitis C recurrence.
|
|
Academic Article
|
Retransplantation for hepatitis C: results of a U.S. multicenter retransplant study.
|
|
Academic Article
|
The changing epidemiology of hepatitis C virus infection in the United States: National Health and Nutrition Examination Survey 2001 through 2010.
|
|
Academic Article
|
Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents--a potentially lethal cocktail.
|
|
Academic Article
|
Genetic susceptibility to hepatitis E viral infection: An enigmatic virus gives up a secret.
|
|
Academic Article
|
Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B.
|
|
Academic Article
|
Current epidemiology of hepatitis E virus infection in the United States: low seroprevalence in the National Health and Nutrition Evaluation Survey.
|
|
Academic Article
|
Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation.
|
|
Academic Article
|
Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes.
|
|
Academic Article
|
Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection.
|
|
Academic Article
|
PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus.
|
|
Academic Article
|
Noninvasive diagnosis of acute cellular rejection in liver transplant recipients: a proteomic signature validated by enzyme-linked immunosorbent assay.
|
|
Academic Article
|
Ultrasound-based transient elastography for the detection of hepatic fibrosis in patients with recurrent hepatitis C virus after liver transplantation: a systematic review and meta-analysis.
|
|
Academic Article
|
Single- and multiple-ascending-dose studies of the NS3 protease inhibitor asunaprevir in subjects with or without chronic hepatitis C.
|
|
Academic Article
|
Serum albumin level is a notable profiling factor for non-B, non-C hepatitis virus-related hepatocellular carcinoma: A data-mining analysis.
|
|
Academic Article
|
How important is acute cellular rejection?
|
|
Academic Article
|
Victory and defeat at Heraclea - treating hepatitis C infection following liver transplantation with telaprevir and boceprevir.
|
|
Academic Article
|
Metabolic syndrome and liver transplantation: a review and guide to management.
|
|
Academic Article
|
The course of posttransplant hepatitis C infection: comparative impact of donor and recipient source of the favorable IL28B genotype and other variables.
|
|
Academic Article
|
Interleukin-28B polymorphism in hepatitis C and liver transplantation.
|
|
Academic Article
|
Comparative effectiveness of telaprevir-based triple therapy in patients with chronic hepatitis C.
|
|
Academic Article
|
Treatment of HCV prior to liver transplantation to prevent HCV recurrence - wise or wasteful?
|
|
Academic Article
|
Sofosbuvir and Velpatasvir Combination Improves Patient-reported Outcomes for Patients With HCV Infection, Without or With Compensated or Decompensated Cirrhosis.
|
|
Academic Article
|
Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis.
|
|
Academic Article
|
Hepatitis C Virus RNA Persists in Liver Explants of Most Patients Awaiting Liver Transplantation Treated With an Interferon-Free Regimen.
|
|
Academic Article
|
On-treatment HCV RNA in patients with varying degrees of fibrosis and cirrhosis in the SOLAR-1 trial.
|
|
Academic Article
|
Alcoholic Liver Disease and Liver Transplantation.
|
|
Academic Article
|
Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells.
|
|
Academic Article
|
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease.
|
|
Academic Article
|
Prevalence and clinical consequences of Hepatitis E in patients who underwent liver transplantation for chronic Hepatitis C in the United States.
|
|
Academic Article
|
Sofosbuvir and Velpatasvir for Patients with HCV Infection.
|
|
Academic Article
|
Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
|
|
Academic Article
|
International Liver Transplant Society Consensus Statement on HEPATITIS C MANAGEMENT IN LIVER TRANSPLANT CANDIDATES.
|
|
Academic Article
|
International Liver Transplant Society Consensus Statement on HEPATITIS C MANAGEMENT IN LIVER TRANSPLANT RECIPIENTS.
|
|
Academic Article
|
Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertension.
|
|
Academic Article
|
Patient-reported outcomes with sofosbuvir and velpatasvir with or without ribavirin for hepatitis C virus-related decompensated cirrhosis: an exploratory analysis from the randomised, open-label ASTRAL-4 phase 3 trial.
|
|
Academic Article
|
International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates.
|
|
Academic Article
|
International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients.
|
|
Academic Article
|
The American Society of Transplantation Consensus Conference on the Use of Hepatitis C Viremic Donors in Solid Organ Transplantation.
|
|
Academic Article
|
International Liver Transplantation Society Asian Consensus on the Management of Hepatitis C Virus Infection in Resource Limited Setting-From Noncirrhotic to Decompensated Disease and After Liver Transplantation.
|
|
Academic Article
|
Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection.
|
|
Academic Article
|
Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of Hepatitis C Virus (HCV)-Viremic Donors Into HCV-Negative Recipients: Outcomes Following Liver Transplant of HCV-Viremic Donors.
|
|
Academic Article
|
Improved Graft Survival After Liver Transplantation for Recipients With Hepatitis C Virus in the Direct-Acting Antiviral Era.
|
|
Academic Article
|
Asian consensus recommendations on optimizing the diagnosis and initiation of treatment of hepatitis B virus infection in resource-limited settings.
|
|
Academic Article
|
Liver transplantation for alcoholic hepatitis in the United States: Excellent outcomes with profound temporal and geographic variation in frequency.
|
|
Academic Article
|
Liver Transplantation of HCV-viremic Donors Into HCV-negative Recipients in the United States: Increasing Frequency With Profound Geographic Variation.
|
|
Academic Article
|
An expert review on the use of tenofovir alafenamide for the treatment of chronic hepatitis B virus infection in Asia.
|
|
Academic Article
|
The Authors' Reply: Geographic Variation in the Utilization of HCV-viremic Donors Into HCV-negative Recipients.
|
|
Grant
|
REDUCTION OF HCV RECURRANCE AFTER LIVER TRANSPLANTATION
|
|
Academic Article
|
Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis.
|
|
Academic Article
|
Macrophage RAGE activation is proinflammatory in NASH.
|